At the Annual General Meeting of Diamyd Medical AB (publ) held on November 30, 2023, Karin Rosén, M.D, PhD, was elected as a new member of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.88 SEK | +3.03% | -2.51% | +65.60% |
18/04 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
12/04 | Recruitment Milestone Reaches in Diamyd® Phase 3 Trial | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.60% | 103M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- DMYD B Stock
- News Diamyd Medical AB
- Diamyd Medical AB Elects Karin Rosén as A New Member of the Board